Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature

Pedro Horna, Haipeng Shao, Afshan Idrees, L. Frank Glass, Carlos A. Torres-Cabala

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Indeterminate dendritic cell neoplasm (IDCN) is an exceedingly rare and mostly cutaneous histiocytosis, frequently associated with other hematopoietic malignancies. We report 2 cases of multilesional cutaneous IDCN. A 55-year-old male with no associated malignancy and complete response to ultraviolet phototherapy; and a 72-year-old male with chronic myelomonocytic leukemia (CMML). Both cases showed histiocytoid cytology, positivity for CD1a and no expression of langerin or BRAFV600E. With our patients, the literature describes 79 cases of IDCNs, including 65 (82%) with only skin involvement, 7 cases (9%) with involvement of skin and a second site, 5 cases (6%) involving lymph nodes only, 1 splenic lesion and 1 systemic disease. Seventeen cases (22%) were associated with other hematopoietic malignancies, most commonly CMML (6 cases), follicular lymphoma (4 cases) and acute myeloid leukemia (3 cases). All IDCNs associated with myeloid malignancies were limited to the skin, while most cases associated with lymphoma were limited to lymph nodes. Reported responses of cutaneous lesions to ultraviolet phototherapy are encouraging, while systemic chemotherapy is appropriate for clinically aggressive cases and treatment of associated malignancies. Recognition of the clinico-morphologic spectrum of IDCNs should prevent misdiagnoses and prompt investigation of possible associated neoplasms.

Original languageEnglish (US)
Pages (from-to)958-963
Number of pages6
JournalJournal of Cutaneous Pathology
Volume44
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Langerhans Cells
varespladib methyl
Skin
Leukemia, Myelomonocytic, Chronic
Neoplasms
Phototherapy
Hematologic Neoplasms
Lymph Nodes
Histiocytosis
Follicular Lymphoma
Diagnostic Errors
Acute Myeloid Leukemia
Dendritic Cells
Cell Biology
Lymphoma
Drug Therapy

Keywords

  • dendritic cell neoplasm
  • indeterminate cell histiocytosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this

Indeterminate dendritic cell neoplasm of the skin : A 2-case report and review of the literature. / Horna, Pedro; Shao, Haipeng; Idrees, Afshan; Glass, L. Frank; Torres-Cabala, Carlos A.

In: Journal of Cutaneous Pathology, Vol. 44, No. 11, 01.11.2017, p. 958-963.

Research output: Contribution to journalArticle

Horna, Pedro ; Shao, Haipeng ; Idrees, Afshan ; Glass, L. Frank ; Torres-Cabala, Carlos A. / Indeterminate dendritic cell neoplasm of the skin : A 2-case report and review of the literature. In: Journal of Cutaneous Pathology. 2017 ; Vol. 44, No. 11. pp. 958-963.
@article{48a971c6208449ed8890d971445b57ac,
title = "Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature",
abstract = "Indeterminate dendritic cell neoplasm (IDCN) is an exceedingly rare and mostly cutaneous histiocytosis, frequently associated with other hematopoietic malignancies. We report 2 cases of multilesional cutaneous IDCN. A 55-year-old male with no associated malignancy and complete response to ultraviolet phototherapy; and a 72-year-old male with chronic myelomonocytic leukemia (CMML). Both cases showed histiocytoid cytology, positivity for CD1a and no expression of langerin or BRAFV600E. With our patients, the literature describes 79 cases of IDCNs, including 65 (82{\%}) with only skin involvement, 7 cases (9{\%}) with involvement of skin and a second site, 5 cases (6{\%}) involving lymph nodes only, 1 splenic lesion and 1 systemic disease. Seventeen cases (22{\%}) were associated with other hematopoietic malignancies, most commonly CMML (6 cases), follicular lymphoma (4 cases) and acute myeloid leukemia (3 cases). All IDCNs associated with myeloid malignancies were limited to the skin, while most cases associated with lymphoma were limited to lymph nodes. Reported responses of cutaneous lesions to ultraviolet phototherapy are encouraging, while systemic chemotherapy is appropriate for clinically aggressive cases and treatment of associated malignancies. Recognition of the clinico-morphologic spectrum of IDCNs should prevent misdiagnoses and prompt investigation of possible associated neoplasms.",
keywords = "dendritic cell neoplasm, indeterminate cell histiocytosis",
author = "Pedro Horna and Haipeng Shao and Afshan Idrees and Glass, {L. Frank} and Torres-Cabala, {Carlos A.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/cup.13017",
language = "English (US)",
volume = "44",
pages = "958--963",
journal = "Journal of Cutaneous Pathology",
issn = "0303-6987",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Indeterminate dendritic cell neoplasm of the skin

T2 - A 2-case report and review of the literature

AU - Horna, Pedro

AU - Shao, Haipeng

AU - Idrees, Afshan

AU - Glass, L. Frank

AU - Torres-Cabala, Carlos A.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Indeterminate dendritic cell neoplasm (IDCN) is an exceedingly rare and mostly cutaneous histiocytosis, frequently associated with other hematopoietic malignancies. We report 2 cases of multilesional cutaneous IDCN. A 55-year-old male with no associated malignancy and complete response to ultraviolet phototherapy; and a 72-year-old male with chronic myelomonocytic leukemia (CMML). Both cases showed histiocytoid cytology, positivity for CD1a and no expression of langerin or BRAFV600E. With our patients, the literature describes 79 cases of IDCNs, including 65 (82%) with only skin involvement, 7 cases (9%) with involvement of skin and a second site, 5 cases (6%) involving lymph nodes only, 1 splenic lesion and 1 systemic disease. Seventeen cases (22%) were associated with other hematopoietic malignancies, most commonly CMML (6 cases), follicular lymphoma (4 cases) and acute myeloid leukemia (3 cases). All IDCNs associated with myeloid malignancies were limited to the skin, while most cases associated with lymphoma were limited to lymph nodes. Reported responses of cutaneous lesions to ultraviolet phototherapy are encouraging, while systemic chemotherapy is appropriate for clinically aggressive cases and treatment of associated malignancies. Recognition of the clinico-morphologic spectrum of IDCNs should prevent misdiagnoses and prompt investigation of possible associated neoplasms.

AB - Indeterminate dendritic cell neoplasm (IDCN) is an exceedingly rare and mostly cutaneous histiocytosis, frequently associated with other hematopoietic malignancies. We report 2 cases of multilesional cutaneous IDCN. A 55-year-old male with no associated malignancy and complete response to ultraviolet phototherapy; and a 72-year-old male with chronic myelomonocytic leukemia (CMML). Both cases showed histiocytoid cytology, positivity for CD1a and no expression of langerin or BRAFV600E. With our patients, the literature describes 79 cases of IDCNs, including 65 (82%) with only skin involvement, 7 cases (9%) with involvement of skin and a second site, 5 cases (6%) involving lymph nodes only, 1 splenic lesion and 1 systemic disease. Seventeen cases (22%) were associated with other hematopoietic malignancies, most commonly CMML (6 cases), follicular lymphoma (4 cases) and acute myeloid leukemia (3 cases). All IDCNs associated with myeloid malignancies were limited to the skin, while most cases associated with lymphoma were limited to lymph nodes. Reported responses of cutaneous lesions to ultraviolet phototherapy are encouraging, while systemic chemotherapy is appropriate for clinically aggressive cases and treatment of associated malignancies. Recognition of the clinico-morphologic spectrum of IDCNs should prevent misdiagnoses and prompt investigation of possible associated neoplasms.

KW - dendritic cell neoplasm

KW - indeterminate cell histiocytosis

UR - http://www.scopus.com/inward/record.url?scp=85028943075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028943075&partnerID=8YFLogxK

U2 - 10.1111/cup.13017

DO - 10.1111/cup.13017

M3 - Article

C2 - 28880462

AN - SCOPUS:85028943075

VL - 44

SP - 958

EP - 963

JO - Journal of Cutaneous Pathology

JF - Journal of Cutaneous Pathology

SN - 0303-6987

IS - 11

ER -